EUVIMEDEUVIMED entdecken
Crossref

Influence of ABCB1 3435C>T Polymorphism on Methotrexate Safety in Patients with Psoriasis — A Secondary Publication

Аlexey А. Кubanov, Аnastasiia V. Аsoskova, Michael S. Zastrozhin, Zhannet A. Sozaeva, Dmitry A. Sychev

Dermatological Health · 2024

DOI: 10.26689/dh.v2i1.6496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatological Health, 2024. Verfasst von Аlexey А. Кubanov und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Methotrexate is a highly effective systemic treatment for moderate to severe psoriasis, but drug toxicity may limit its use. Recent evidence suggests that it is necessary to take into account the individual characteristics of methotrexate pharmacokinetics, which are determined by the presence of polymorphisms of genes encoding methotrexate carrier proteins, to predict the risk of methotrexate-induced toxicity.

Aim

The research aims to assess the associations of ABCB1 rs1045642 (3435C>T) polymorphism with methotrexate safety for patients with moderate and severe psoriasis.

Methods

The study included 75 psoriasis patients treated with methotrexate with 21 days of follow-up duration. Data on adverse drug reactions (ADR) were collected using a clinically structured questionnaire, and complete and biochemical blood tests, and urinalysis were performed. The severity of ADR was assessed using visual analog scales and the CTCAE toxicity scale. The severity of gastrointestinal ADR was assessed using the GSRS questionnaire. Genotyping was carried out by real-time PCR.

Results

Gastrointestinal toxicity was detected in 38 patients (50.67%). The mean GSRS score was 7.97 ± 9.18. Analysis of differences in the ADR incidence showed the presence of statistically significant differences in the frequency of ADR in the gastrointestinal tract: the toxic effect of methotrexate was more often observed in carriers of the T allele of the ABCB1 rs1045642 polymorphism (3435C>T), (CC: 2 (14.3%), TC: 18 (52.9%), TT: 18 (66.7%), P = 0.006). Binomial regression demonstrated the presence of a statistically significant effect of the rs1045642 single-nucleotide polymorphism of the ABCB1 gene on the incidence of ADR from the gastrointestinal tract (OR = 8.64, P = 0.008).

Conclusion

An association of ABCB1 rs1045642 single-nucleotide polymorphism with the safety of methotrexate therapy in patients with moderate and severe psoriasis was revealed. The data obtained can be used to personalize the prescription of methotrexate to psoriasis patients.

Zitieren

APA

Кubanov, А. А., Аsoskova, А. V., Zastrozhin, M. S., Sozaeva, Z. A., & Sychev, D. A. (2024). Influence of ABCB1 3435C>T Polymorphism on Methotrexate Safety in Patients with Psoriasis — A Secondary Publication. Dermatological Health. https://doi.org/10.26689/dh.v2i1.6496

Vancouver

Кubanov АА, Аsoskova АV, Zastrozhin MS, Sozaeva ZA, Sychev DA. Influence of ABCB1 3435C>T Polymorphism on Methotrexate Safety in Patients with Psoriasis — A Secondary Publication. Dermatological Health. 2024. doi:10.26689/dh.v2i1.6496

BibTeX
@article{ubanov2024,
  author = {Кubanov, Аlexey А. and Аsoskova, Аnastasiia V. and Zastrozhin, Michael S. and Sozaeva, Zhannet A. and Sychev, Dmitry A.},
  title = {Influence of ABCB1 3435C>T Polymorphism on Methotrexate Safety in Patients with Psoriasis — A Secondary Publication},
  journal = {Dermatological Health},
  year = {2024},
  doi = {10.26689/dh.v2i1.6496}
}
Kostenlos starten →